BSG and hepatocellular carcinoma: We performed cell proliferation assays to evaluate the effect of Mehozumab‐DM1 on hepatocellular carcinoma cell lines HCC‐LM3, MHCC97‐H, and Huh‐7, which were found to highly express CD147 according to our previous studies.